• Search
  • Helpdesk
  • Sales contact
Get your demo

The strengths of electronic Clinical Outcome Assessment (eCOA) versus paper solutions

eCOAScientific advice
Last updated: July 22, 2025

In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as:

  • Accuracy
  • Completeness
  • Timings
  • Attributability
  • User-friendliness
  • Regulatory compliance
Download the "eCOA vs paper" infographic
Ask for a demo
Follow us on social media
Subscribe to our newsletter
You may also like

How Kayentis Delivered eCOA Go-Live in Just 5 Weeks for...

Turning endpoint noise into reliable CNS trial data

Kayentis publishes its first ESG report, strengthening its commitment to...

Kayentis launches interactive eConsent solution to simplify and improve patient...

Better Raters, Smarter eCOA, Stronger Data

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical...

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.
Meet us at the following events

ISOQOL 2026

18-21 OCT 2026 • Prague, Czech Republic
33rd Annual Conference | ISOQOL  

CTAD Clinical Trial on Alzheimer’s Disesases

16-19 NOV 2026 • Boston, MA, USA
  Meet our colleague Anna Dudalyan at CTAD. Schedule a meeting
Turning endpoint noise into reliable CNS trial data
Discover how lifecycle rater training and eCOA work together to improve endpoint quality
  • Download the white paper